Czerkinsky C, Svennerholm A M, Quiding M, Jonsson R, Holmgren J
Department of Medical Microbiology and Immunology, University of Göteborg, Sweden.
Infect Immun. 1991 Mar;59(3):996-1001. doi: 10.1128/iai.59.3.996-1001.1991.
We examined whether immunization with a newly developed oral cholera vaccine would elicit gut-derived antibody-producing cells in the blood and in distant mucosal tissues, such as the minor salivary glands, in 30 adult Swedish volunteers. The results of this study demonstrated that this vaccine indeed induced production of specific antibody-producing cells against the cholera toxin B subunit in both peripheral blood and salivary glands. The response in blood, which after primary and booster immunizations comprised both immunoglobulin A (IgA) and IgG antibody-forming cells, was highly transient and preceded the response in salivary glands; the latter response was restricted to the IgA isotype. The results provide further evidence of the existence of a common mucosal immune system in humans. Furthermore, these findings support previous observations that in animals, the cholera toxin B subunit may be a useful carrier protein for preparing enteric vaccines against pathogens encountered at intestinal and extraintestinal mucosal sites.
我们检测了一种新研发的口服霍乱疫苗免疫接种是否会在30名成年瑞典志愿者的血液以及远处的黏膜组织(如小唾液腺)中引发源自肠道的抗体产生细胞。这项研究的结果表明,这种疫苗确实能诱导外周血和唾液腺中产生针对霍乱毒素B亚单位的特异性抗体产生细胞。血液中的反应,在初次和加强免疫后包括免疫球蛋白A(IgA)和IgG抗体形成细胞,是高度短暂的,且先于唾液腺中的反应;后者的反应仅限于IgA同种型。这些结果进一步证明了人类中存在共同黏膜免疫系统。此外,这些发现支持了之前的观察结果,即在动物中,霍乱毒素B亚单位可能是一种有用的载体蛋白,用于制备针对在肠道和肠外黏膜部位遇到的病原体的肠道疫苗。